Sökning: WFRF:(Pasquini Marcelo C.) >
Effect of body mass...
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.
-
Aplenc, Richard (författare)
-
Zhang, Mei-Jie (författare)
-
Sung, Lillian (författare)
-
visa fler...
-
Zhu, Xiaochun (författare)
-
Ho, Vincent T (författare)
-
Cooke, Kenneth (författare)
-
Dvorak, Christopher (författare)
-
Hale, Gregory (författare)
-
Isola, Luis M (författare)
-
Lazarus, Hillard M (författare)
-
McCarthy, Philip L (författare)
-
- Olsson, Richard (författare)
- Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)
-
Pulsipher, Michael (författare)
-
Pasquini, Marcelo C (författare)
-
Bunin, Nancy (författare)
-
visa färre...
-
(creator_code:org_t)
- American Society of Hematology, 2014
- 2014
- Engelska.
-
Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 123:22, s. 3504-11
- Relaterad länk:
-
https://europepmc.or...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- The rising incidence of pediatric obesity may significantly affect bone marrow transplantation (BMT) outcomes. We analyzed outcomes in 3687 children worldwide who received cyclophosphamide-based BMT regimens for leukemias between 1990 and 2007. Recipients were classified according to age-adjusted body mass index (BMI) percentiles as underweight (UW), at risk of UW (RUW), normal, overweight (OW), or obese (OB). Median age and race were similar in all groups. Sixty-one percent of OB children were from the United States/Canada. Three-year relapse-free and overall survival ranged from 48% to 52% (P = .54) and 55% to 58% (P = .81) across BMI groups. Three-year leukemia relapses were 33%, 33%, 29%, 25%, and 21% in the UW, RUW, normal, OW, and OB groups, respectively (P < .001). Corresponding cumulative incidences for transplant-related mortality (TRM) were 18%, 19%, 21%, 22%, and 28% (P < .01). Multivariate analysis demonstrated a decreased risk of relapse compared with normal BMI (relative risk [RR] = 0.73; P < .01) and a trend toward higher TRM (RR = 1.28; P = .014). BMI in children is not significantly associated with different survival after BMT for hematologic malignancies. Obese children experience less relapse posttransplant compared with children with normal BMI; however, this benefit is offset by excess in TRM.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Blood
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Aplenc, Richard
-
Zhang, Mei-Jie
-
Sung, Lillian
-
Zhu, Xiaochun
-
Ho, Vincent T
-
Cooke, Kenneth
-
visa fler...
-
Dvorak, Christop ...
-
Hale, Gregory
-
Isola, Luis M
-
Lazarus, Hillard ...
-
McCarthy, Philip ...
-
Olsson, Richard
-
Pulsipher, Micha ...
-
Pasquini, Marcel ...
-
Bunin, Nancy
-
visa färre...
- Artiklar i publikationen
-
Blood
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet